Patent · US Active

1,2,4-triazine derivatives for the treatment of viral infections

US9416114B2 · kind B2 · utility

26Cited by

1References

7Claims

0Family size

Assignees

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
UNIVERSITE DE ROUEN · FR
INSTITUT NATIONAL DES SCIENCES APPLIQUÉES DE LYON · FR

Inventors

Vincent Gembus · Rouen, FR
Philippe Jubault · Préaux, FR
Christophe Hoarau · Bois-Guillaume, FR
Vincent Levacher · Fontaine-sous-Préaux, FR
Jean-François Bonfanti · Andé, FR
David Graig McGowan · Beerse, BE
Jérôme Emile Georges Guillemont · Andé, FR

Key dates

Filing date	Oct 1, 2013
Grant date	Aug 16, 2016
Priority date	—
Expiry date	Oct 1, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention relates to 1,2,4-triazine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.